/

Società

AM

Società

AMSBIOPHARMA

Di cosa scriviamo

FarmaciaMusicaSaluteSanitàUniversità

38 comunicati stampa

Guarda tutti i comunicati

Press Release cover image

19/05/2026

Musica

Salute

Sanità

ICH Q11 drug substance development strategies | AMSbiopharma

Fonte

1.00

0

Press Release cover image

13/05/2026

Salute

Farmacia

Sanità

ICH Q8 pharmaceutical development and QbD strategies | AMSbiopharma

Fonte

1.00

0

Press Release cover image

29/04/2026

Salute

Sanità

Peptide purification methods in drug development | AMSbiopharma

Fonte

1.00

0

Press Release cover image

16/04/2026

Salute

Sanità

Metabolomics and lipidomics in drug development | AMSbiopharma

Fonte

1.00

0

Press Release cover image

24/03/2026

Università

Salute

Sanità

Drug development timeline and regulatory delays | AMSbiopharma

Fonte

1.00

0

Press Release cover image

11/03/2026

Musica

Salute

Sanità

CMC in the drug development process and IND analytical strategy | AMSbiopharma

Fonte

1.00

0

Press Release cover image

26/02/2026

Salute

Sanità

Gene and cell therapy analytical strategies and compliance | AMSbiopharma

Fonte

1.00

0

Press Release cover image

19/02/2026

Salute

Farmacia

Sanità

EMA nitrosamines update and acceptable intake limits | AMSbiopharma

Fonte

1.00

0

Press Release cover image

05/02/2026

Salute

Sanità

Fit-for-purpose QC protocols for nucleic acid therapeutics | AMSbiopharma

Fonte

1.00

0

Press Release cover image

03/02/2026

Università

Salute

Sanità

How analytical CROs empower biotech innovation | AMSbiopharma

Fonte

1.00

0

Seguaci

0

Compatibilità

0